Oral insulin: The future of insulin therapy?

Can Remote Decentralised Clinical Trials enhance clinical research?

Can serious games motivate teenagers with diabetes to adhere to their treatment?

β3-adrenoceptor agonist Mirabegron – a candidate anti-obesity drug?

Once-weekly basal insulin analogue in clinical development

Glycemic control in type 1 diabetes – effects of diabetes technology and socioeconomic status

The rollercoaster life of inhaled insulin

Heart failure: SGLT2 inhibitors moving beyond diabetes

Bringing the real world to clinical research: the use of wearables in pivotal trials

Think Tank highlights CROs role the adoption of AI-powered health innovation